Neutrophil secretory defect in the gray platelet syndrome: a new case

H Chedani, E Dupuy, JM Massé, EM Cramer - Platelets, 2006 - Taylor & Francis
H Chedani, E Dupuy, JM Massé, EM Cramer
Platelets, 2006Taylor & Francis
We report the case of a 60-year-old woman who was newly diagnosed for the gray platelet
syndrome (GPS). This patient had long-term thrombocytopenia which had been initially
misdiagnosed as idiopathic thrombocytopenic purpura (ITP). Blood smear displayed
characteristic gray platelets, allowing the diagnosis to be made, which was confirmed by
electron microscopy (EM). Polymorphonuclear neutrophils (PMN) appeared poorly
granulated on the May–Grunwald–Giemsa-stained blood smear. Flow cytometry analysis of …
We report the case of a 60-year-old woman who was newly diagnosed for the gray platelet syndrome (GPS). This patient had long-term thrombocytopenia which had been initially misdiagnosed as idiopathic thrombocytopenic purpura (ITP). Blood smear displayed characteristic gray platelets, allowing the diagnosis to be made, which was confirmed by electron microscopy (EM). Polymorphonuclear neutrophils (PMN) appeared poorly granulated on the May–Grunwald–Giemsa-stained blood smear. Flow cytometry analysis of PMN demonstrated increased expression of CD35, CD11b and CD18 at resting PMN surface, without any changes after fMLP stimulation. Ultrastructural study retrieved a decreased number of myeloperoxidase (MPO)-negative secondary granules in PMN. Immunolabeling confirmed the presence of membrane proteins and the absence of soluble content in platelet and megakaryocyte (MK) α-granules, and the decrease of secondary granules and secretory vesicles in PMN. This new observation demonstrates that the impairment of the secretory compartment of PMN is definitely a hallmark of GPS, and that the detection of these subtle abnormalities should be searched with adequate and up-to-date technical approaches.
Taylor & Francis Online